Duchenne muscular dystrophy is caused by the absence of functional dystrophin, leading to the myofiber membrane instability and progressive muscle atrophy. Myoblast transplantation in dystrophic muscles is a potential therapy, as it permits the long-term restoration of dystrophin expression in transplanted muscles. However, the success of this approach is limited by the short period of muscle repair following myoblast transplantation. Myostatin, a powerful inhibitor of muscle growth, is involved in terminating the period of muscle repair following injury by reducing myoblast proliferation and differentiation. Follistatin forms a complex with myostatin, preventing its interaction with its receptor and thus blocking the myostatin signal.
INTRODUCTION
Myostatin, also called growth and differentiation factor-8, belongs to the superfamily of transforming growth factor-β. It is predominantly expressed in skeletal mus-Duchenne muscular dystrophy (DMD), a severe Xlinked genetic disease, is the most severe dystrophy in cle, which suggests that it plays an important role in regulating muscle development (17) . The great muscle children. It affects one male in 3,500 at birth (3). The disease is due to a mutation of the dystrophin gene, re-hypertrophy phenotype of mice lacking myostatin gene suggested that myostatin normally regulates negatively sulting into the absence of that submembrane protein.
Dystrophin is a 427-kDa protein expressed in myofibers, muscle growth (17). In fact, myostatin reduces the proliferation and differentiation of both myoblasts and sat-where it provides a link between the extracellular matrix and the cytoskeleton (6). The absence of dystrophin in-ellites cells (16, 24, 30) . As the other members of the TGF-β family, myostatin is synthesized as a precursor duces an instability of the myofiber membrane and progressive degeneration of muscle tissue (25) . Normal my-protein that undergoes two proteolytic processing to generate the biologically active molecule (17). The first oblasts transplanted in dystrophic muscles fuse with damaged host myofibers, forming hybrid fibers, which cleavage removes the N-terminal signal necessary for targeting the protein to the secretion pathway, and the express dystrophin (21) . The limited period of muscle regeneration that follows muscle injury reduces the suc-second one generates the C-terminal fragment, which possesses the receptor binding activity. The N-terminal cess of the therapeutic approach. This can be bypassed by repetitive cell injection very close to each other, as fragment following the second proteolytic processing has been referred as the propeptide; this propeptide demonstrated by our group (27) .
plays an important role in regulating the activity of ma-trypsin and 0.02% EDTA (Gibco). Dissociated cells were grown in a modified MB1 medium (Hyclone, South ture myostatin in vivo (13). In addition to the propeptide, several other proteins have also been shown to be Logan, UT, USA) containing 10% fetal bovine serum (FBS) (Gibco, Burlington, Ontario, CA), 10 ng/ml basic capable of binding and inhibiting myostatin (4,5,20,31). One of these is follistatin protein, and this inhibition oc-fibroblast growth factor (bFGF) (Strathmann Biotec AG, Hamburg, Germany), and 1% penicillin-streptomycin in curs after the formation of a latent complex formed by active myostatin and follistatin (13). Indeed, it has been a humidified atmosphere with 5% CO 2 at 37°C. Differentiation was induced by rinsing the cultures and switch-reported that transgenic mice overexpressing the follistatin protein show an increased muscle mass similar to ing them to DMEM medium containing 2% FBS for 2 days. that observed in transgenic mice lacking myostatin (2, 13) , while a lack of functional follistatin causes a im-Construction of a Lentivirus Vector portant reduction in muscle mass at birth (15) .
and Viral Preparation In addition, Minetti et al. showed that treatment of mdx mice with deacetylase inhibitor (trichostatin A) re-
The follistatin lentivirus vector was constructed in our laboratory from a plasmid coding for the human fol-sults in an increase in the size of myofibers by inducing expression of the myostatin antagonist follistatin in sat-listatin short form received from Dr. Lee's laboratory. For that, the follistatin transgene was cloned in a lentivi-ellite cells, and that this conferred to dystrophic muscles resistance to contraction-coupled degeneration and alle-rus vector under the control of a CMV promoter (pCMV-hFst). A lentivirus vector coding for the eGFP was used viated both morphological and functional consequences of the primary genetic defect (19) . Follistatin is a se-as a control (Fig. 1a ). The day before the transfection, 4 × 10 6 of 293T cells were plated in 10-cm culture dishes in creted protein glycoprotein encoded by a single gene that is subject to alternative splicing. This mechanism DMEM proliferation medium supplemented with 10% FBS and 1% penicillin-streptomycin. Cells were then generates two different forms of the protein: the short (FS288) and the long (FS 315) form of follistatin (26) .
transfected with 15 µg of pCMV-hFst vector using the CaCl 2 transfection method to produce the follistatin len-The short form of follistatin lacks the acidic tail in the C-terminal, which permits the protein to bind the extra-tivirus. As a control, 293T cells were transfected with 15 µg of pCMV-eGFP vector. In both cases, cells were cellular matrix and thus to be less diluted in the circulation (8).
cotransfected with 6.5 µg of GP, 3.5 µg of VSVG, and 2.5 µg of REV plasmids to permit the production of the The objective of our experiments was first to genetically modify human myoblasts with a recombinant len-viral particles. Cells were incubated overnight in proliferation medium. The day after transfection, cells were tivirus to overexpress the follistatin short form protein to increase their proliferation and/or differentiation rates washed with HBSS and fresh proliferation medium was added to each dish. The supernatant containing produced and to measure the success of the transplantation of these genetically modified myoblasts in immunodefi-hFst lentivirus and control eGFP lentiviruses were collected from transfected 293T cells 48, 72, and 96 h after cient SCID mouse muscles.
transfection. The lentivirus was then frozen immediately MATERIALS AND METHODS in liquid nitrogen and stored at −80°C until transduction.
Animals
Transduction of Normal Human Myoblasts With GFP All the experiments were approved by the animal or hFst Lentivirus care committee of the CHUL (Centre Hospitalier de
The day before the transduction, 250,000 human myl'Université Laval). Severe combined immunodeficienoblasts were plated into six-well plates. Cells were transcy disease (SCID) mice were purchased from Charles duced with pCMV-eGFP or pCMV-hFst lentiviral parti-River (Toronto, Ontario, CA).
cles in the presence of 6 µg/ml of polybrene. Cells were Cell Lines washed twice with HBSS 24 h after transduction to remove all viral particles. Cells were then proliferated. 293T cells were grown in DMEM (Gibco, Burlington, Ontario, CA) proliferation medium complemented During the culture, cells were transferred in T-75 flasks. with 10% FBS (Invitrogen, Burlington, Ontario, CA)
Detection of Human Follistatin by Immunocytochemistry and 1% penicillin-streptomycin (Gibco). Myogenic cells were released from minced fragments of muscle biopsy
The eGFP was directly visualized under a fluorescent microscope. An immunocytochemistry assay was per-by enzymatic dissociation. After 1 h of incubation in collagenase (600 U/ml) (Sigma-Aldrich, St. Louis, MO, formed on pCMV-eGFP and pCMV-hFst lentivirus transduced cells to verify the expression of the human follis-USA), cells were then incubated for 30 min in Hank's buffer salt solution (HBSS) (Gibco) containing 0.1% tatin in transduced cells. Cells were first fixed for 15 min with ethanol 95% and nonspecific binding sites Fusion Index were blocked for 1 h with PBS containing 10% FBS.
pCMV-eGFP-and pCMV-hFst transduced cells were Cells were first incubated with monoclonal mouse antiplated in a 24-well plate at 40,000 cells/well in proliferahuman follistatin primary antibody (R&D Systems, tion medium. One day later, cells were rinsed with Minneapolis, MN, USA) in PBS 1% FBS (at 25 µg/ml) HBSS and incubated in a differentiation medium (DMEM for 1 h followed by an anti-mouse IgG conjugated with containing 2% FBS), in the presence or in the absence Alexa 546 (Molecular Probes, Burlington, Ontario, CA) of recombinant myostatin in a humidified atmosphere (1:300) for 1 h. Finally, nuclei were stained with DAPI.
with 5% CO 2 at 37°C for 2 days. Fresh differentiation medium with or without recombinant myostatin was re-Detection of the Human Follistatin by Western Blot placed daily. Cells were then fixed in 4% paraformaldehyde for 15 min, and permeabilized with 3% Triton A Western blot was made with extracts from pCMV-X-100 in PBS for 3 × 15 min. Myotubes were immuno-eGFP and pCMV-hFst lentivirus transduced cells to stained with a mouse anti-myosin heavy chain antibody quantify the expression of human follistatin. Cells were (1:100 for 2 h), followed by an anti-mouse IgG conjufirst sonicated directly in a lysis buffer containing 20 gated with Alexa 546 (1:300 for 1 h). Cell nuclei were mM Tris, pH 7.5, 1 mM DTT, 1 mM PMSF, 1% SDS.
marked with DAPI (1:10000). After the immunocyto-Proteins were then precipitated with methanol and chlochemistry, the fusion index (defined as the number of roform and finally quantified using the amino-black re-DAPI-stained nuclei inside myotubes in a given field agent. After that, 20 µg of protein was separated by divided by the total number of DAPI-stained nuclei in SDS-PAGE under reducing conditions. Follistatin was the same field) of each condition was calculated. The detected by incubating the membrane with a monoclonal assay was performed three times. mouse anti-human follistatin antibody at 25 µg/ml (R&D Systems) and incubating for 1 h. An anti-mouse
In Vivo Animal Studies horseradish peroxidase-coupled antibody (DAKO, Car-hFst transduced human myoblasts (500,000) were pinteria, CA, USA) was used as a second antibody at 1:
transplanted in tibialis anterior muscles of three 3-month-2000 and incubated for 1 h. old SCID mice. Control muscles were transplanted with the same amount of cells transduced with the eGFP len-Immunodetection of Human Follistatin Protein tivirus. For transplantation, cells were detached from the by Dot Blot flasks using Trypsin-EDTA and washed twice with A dot blot against human follistatin was performed HBSS. The cell pellet was resuspended in 10 µl of with the conditioned media of human cells transduced HBSS and slowly injected in muscles using a glass capwith the pCMV-eGFP or with the pCMV-hFst lentivirus illary. Mice were sacrificed 3 weeks later and the cellto verify the follistatin secretion. Then 100 and 500 µl grafted muscles were dissected out and frozen. Serial conditioned medium from eGFP and hFst transduced cryostat sections (12 µm) were prepared throughout the cells was applied to a nitrocellulose membrane. The whole muscle length. membrane was then incubated with a monoclonal mouse anti-human follistatin antibody at 25 µg/ml (R&D Sys-Immunohistochemical Detection of Human Dystrophin tems) for 1 h followed by an anti-mouse horseradish per-Sections were first washed with PBS. Nonspecific oxidase-coupled antibody at 1:2000 for 1 h. binding sites were blocked by incubating the cryostat sections with PBS containing 10% FBS for 1 h. Human Proliferation Test dystrophin was detected with a mouse anti-human dystrophin antibody (Vector Laboratories, Burlington, On-pCMV-eGFP and pCMV-hFst lentivirus transduced tario, CA) (1:50 for 2 h), followed by a biotinylated antihuman myoblasts (2,000 each) were plated in four 24mouse antibody (DAKO) (1:300 for 45 min) and strepwell plates in proliferation medium (DMEM-HG, 10% tavidin-Cy3 (Sigma-Aldrich) (1:300 for 45 min). Sections FBS, 1% penicillin-streptomycin). Cells were synchrowere washed three times with PBS after each antibody nized in serum-free medium for 48 h before the experiincubation. Dystrophin staining was observed on PBSment. The proliferation medium was replaced daily.
glycerol mounted slides under an ultraviolet lamp micro-Cells were rinsed with PBS, blotted, and frozen at scope using a fluorescein isothiocyanate filter. −80°C until analysis. Proliferation was measured at T 0 (48 h after the serum starvation), T 48h , T 72h , and T 96h using Statistical Analysis the Cyquant cell proliferation kit (Molecular Probes) assay according to the manufacturer's protocol. The
The significance of results was evaluated using Student's t-test between groups (Figs. 3 and 5 ) and ANOVA assay was performed three times. proliferation of pCMV-hFst transduced myoblasts was increased when compared with control myoblasts expressing eGFP. This could be explained by the fact that overexpressed follistatin antagonized the inhibitory effect of myostatin present in the proliferation medium.
Overexpressed Follistatin Promoted Human Myoblast Differentiation In Vitro
Recombinant myostatin blocked myoblast fusion and reduced the number of myotubes formed by eGFP and by hFst transduced myoblasts (Fig. 4) . However, myoblasts expressing hFst formed more myosin heavy chain-positive myotubes than control eGFP-expressing cells. This is more evident in the absence of recombinant myostatin; indeed, when treated with the indicated dose (Fig. 4) .
sponding to the fluorescence at T 0 (100%) (n = 3). *p < 0.05.
Overexpressed Follistatin Enhanced the Success of Human Myoblast Transplantation in SCID Mice followed by Bonferroni correction of the t-test within
Human myoblasts transduced either with eGFP or groups (Fig. 4) on GraphPad software.
hFst lentivirus were transplanted in immunodeficient SCID mouse muscles to measure their potential to form RESULTS muscle fibers expressing human dystrophin. An immu-Lentivirus Vector-Induced Follistatin Expression nohistochemistry assay performed on sections of muscle in 293T and Human Myoblasts transplanted either with GFP-or Fst-expressing human myoblasts (Fig. 5a ) was used to count human dystrophin-The ability of lentivirus vector to transduce human adult myoblasts was first assessed. The immunocyto-positive fibers in each condition. Figure 5b shows that the success of the graft was clearly improved in muscles chemistry assay (Figs. 1b, 2a ) showed that pCMV-eGFP transfected or transduced human adult myoblasts were transplanted with myoblasts overexpressing the follistatin. Indeed, only 51 ± 14 hybrid fibers were counted in follistatin negative, whereas pCMV-hFst transfected human myoblasts were all follistatin positive. The protein muscles transplanted with eGFP transduced myoblasts, while 106 ± 6 hybrid fibers were counted in muscle was thus well expressed in transduced cells. To confirm the results of the immunocytochemistry assay, a West-transplanted with hFst transduced myoblasts. ern blot against follistatin was performed on a protein DISCUSSION extract of each cell group (pCMV-eGFP or pCMV-hFst transfected 293T cells and pCMV-eGFP or pCMV-hFst Normal myoblast transplantation in dystrophic muscle constitutes a potential therapy for Duchenne muscu-transduced human myoblasts). The Western blots (Figs. 1c, 2b) clearly confirmed the overexpression of the fol-lar dystrophy. However, the success of this potential therapeutic approach is limited by three major problems: listatin protein by showing a more intense band in pCMV-hFst transfected 293T cells and transduced my-1) the poor survival of transplanted myoblasts, 2) the immune response against transplanted myoblasts, and 3) oblasts in comparison with control cells.
the fusion of the transplanted myoblasts only with the Overexpressed Follistatin Promoted Human Myoblast damaged muscle fibers located near the injection trajec-Proliferation In Vitro tories (28). In addition to those problems, the success of this therapy could be reduced by the short period of For this experiment, myoblasts were first synchronized by serum deprivation for 48 h and complete me-muscle regeneration, which follows muscle injury. Myostatin is the most powerful inhibitor of muscle dium was then added to the cells. Some of the cells died during the first 48 h due to the previous serum depriva-growth and regeneration identified to date (10,17,18). In fact, myostatin is known to regulate negatively both tion. The cells then proliferated. Figure 3 shows that the proliferation and differentiation of myoblasts, by the experiments. The purpose of this work was to evaluate the effects of myostatin signal blockade by follistatin on overexpression of the p21 cyclin-dependent kinase inhibitor (30), and also by downregulating the expression proliferation, differentiation, and transplantation potential of myoblasts. of muscle differentiation-related genes such as MyoD and myogenin (12). Myostatin also regulates muscle re-First, we demonstrated that adult human myoblasts were efficiently transduced with the follistatin-coding generation by blocking satellite cell activation and selfrenewal. Myostatin action is antagonized by several pro-lentivirus and that these cells secreted this protein. Second, our results showed that the action of myostatin on teins, including follistatin, which blocks its interaction with its specific receptor, ActRIIB (activin type II B re-myoblast proliferation and differentiation was blocked when follistatin was overproduced. This effect was ceptor) (1). Moreover, follistatin regulates the expression of the myostatin gene in C 2 C 12 myoblasts (11). In probably mediated by the inhibition of the induction of p21 expression (9,30) and the overexpression of MyoD this study, we used a lentivirus to overexpress the short form of human follistatin in normal human myoblasts.
(12,23) in the absence of myostatin signal. This allowed myoblasts to progress in the cell cycle from the phase An eGFP lentivirus was used as a control for all the
